{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:10:17Z","timestamp":1762459817449,"version":"build-2065373602"},"reference-count":72,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T00:00:00Z","timestamp":1582156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007899","name":"University of Arizona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007899","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.vaccine.2020.02.054","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T08:18:35Z","timestamp":1582618715000},"page":"2960-2970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A bacterial vaccine polypeptide protective against nontypable Haemophilus influenzae"],"prefix":"10.1016","volume":"38","author":[{"given":"Paul W.","family":"Whitby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Morton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huda J.","family":"Mussa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Mirea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terrence L.","family":"Stull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.02.054_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/00222615-18-1-1","article-title":"The pathogenicity of Haemophilus influenzae","volume":"18","author":"Turk","year":"1984","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2020.02.054_b0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00001432-200304000-00009","article-title":"Respiratory infections caused by non-typeable Haemophilus influenzae","volume":"16","author":"Murphy","year":"2003","journal-title":"Curr Opin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.02.054_b0015","article-title":"The pathogenesis of nontypable Haemophilus influenzae otitis media","volume":"19","author":"St Geme 3rd","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.054_b0020","unstructured":"CDC (2019) The Pink Book: Haemophilus influenzae type b, https:\/\/wwwcdcgov\/vaccines\/pubs\/pinkbook\/hibhtml#epi. [accessed 7 October 2019]."},{"key":"10.1016\/j.vaccine.2020.02.054_b0025","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1084\/jem.152.2.361","article-title":"Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates","volume":"152","author":"Schneerson","year":"1980","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2020.02.054_b0030","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/14760584.2018.1484286","article-title":"Update on non-typeable Haemophilus influenzae-mediated disease and vaccine development","volume":"17","author":"Jalalvand","year":"2018","journal-title":"Expert Rev Vaccines"},{"issue":"122\u2013127","key":"10.1016\/j.vaccine.2020.02.054_b0035","article-title":"Ambulatory Visits for Otitis Media before and after the Introduction of Pneumococcal Conjugate Vaccination","volume":"201","author":"Kawai","year":"2018","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2020.02.054_b0040","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijporl.2019.01.023","article-title":"National impact of 13-valent pneumococcal conjugate vaccine on ambulatory care visits for otitis media in children under 5years in the United States","volume":"119","author":"Zhou","year":"2019","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.vaccine.2020.02.054_b0045","doi-asserted-by":"crossref","first-page":"e964","DOI":"10.1542\/peds.2012-3488","article-title":"The diagnosis and management of acute otitis media","volume":"131","author":"Lieberthal","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2020.02.054_b0050","first-page":"140","article-title":"Epidemiology of acute otitis media in the postpneumococcal conjugate vaccine era","author":"Kaur","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2020.02.054_b0055","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S2352-4642(18)30168-8","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccination for protection against acute otitis media caused by Streptococcus pneumoniae in healthy young children: a prospective observational study","volume":"2","author":"Pichichero","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.vaccine.2020.02.054_b0060","doi-asserted-by":"crossref","first-page":"12896","DOI":"10.1073\/pnas.1721095115","article-title":"Impact of existing vaccines in reducing antibiotic resistance: Primary and secondary effects","volume":"115","author":"Klugman","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2020.02.054_b0065","doi-asserted-by":"crossref","first-page":"e00512","DOI":"10.1002\/prp2.512","article-title":"Antibiotic dispensing following pediatric visits in the US emergency departments and outpatient settings from 2006 to 2016","volume":"7","author":"Agiro","year":"2019","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.vaccine.2020.02.054_b0070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13052-019-0696-9","article-title":"Antibiotic prescriptions in acute otitis media and pharyngitis in Italian pediatric outpatients","volume":"45","author":"Barbieri","year":"2019","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.vaccine.2020.02.054_b0075","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/cid\/ciy187","article-title":"Current Epidemiology and Trends in Invasive Haemophilus influenzae Disease-United States, 2009\u20132015","volume":"67","author":"Soeters","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.02.054_b0080","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","article-title":"Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study","volume":"367","author":"Prymula","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.02.054_b0085","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1128\/CVI.00632-13","article-title":"Absence of an important vaccine and diagnostic target in carriage- and disease-related nontypeable Haemophilus influenzae","volume":"21","author":"Smith-Vaughan","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2020.02.054_b0090","doi-asserted-by":"crossref","first-page":"e0136867","DOI":"10.1371\/journal.pone.0136867","article-title":"Antisera against certain conserved surface-exposed peptides of nontypeable Haemophilus influenzae are protective","volume":"10","author":"Whitby","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.02.054_b0095","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1097\/00006454-198901001-00022","article-title":"Evaluation of pilus vaccines for prevention of experimental otitis media caused by nontypable Haemophilus influenzae","volume":"8","author":"Karasic","year":"1989","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.02.054_b0100","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1128\/iai.62.5.2002-2020.1994","article-title":"Role of fimbriae expressed by nontypeable Haemophilus influenzae in pathogenesis of and protection against otitis media and relatedness of the fimbrin subunit to outer membrane protein A","volume":"62","author":"Sirakova","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.02.054_b0105","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cvsm.2017.10.002","article-title":"Recent advances in vaccine technologies","volume":"48","author":"Francis","year":"2018","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1016\/j.vaccine.2020.02.054_b0110","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/infdis\/173.1.180","article-title":"A virulent nonencapsulated Haemophilus influenzae","volume":"173","author":"Nizet","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.02.054_b0115","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2180-13-134","article-title":"The role of the RNA chaperone Hfq in Haemophilus influenzae pathogenesis","volume":"13","author":"Hempel","year":"2013","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.vaccine.2020.02.054_b0120","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1128\/IAI.68.5.2756-2765.2000","article-title":"Passive transfer of antiserum specific for immunogens derived from a nontypeable Haemophilus influenzae adhesin and lipoprotein D prevents otitis media after heterologous challenge","volume":"68","author":"Kennedy","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.02.054_b0125","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1128\/IAI.67.6.2746-2762.1999","article-title":"Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection","volume":"67","author":"Bakaletz","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.02.054_b0130","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1128\/iai.62.5.1710-1718.1994","article-title":"Synergistic effect of adenovirus type 1 and nontypeable Haemophilus influenzae in a chinchilla model of experimental otitis media","volume":"62","author":"Suzuki","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.02.054_b0135","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijmm.2009.03.004","article-title":"The heme-binding protein (HbpA) of Haemophilus influenzae as a virulence determinant","volume":"299","author":"Morton","year":"2009","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.vaccine.2020.02.054_b0140","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/1756-0500-5-327","article-title":"A functional tonB gene is required for both virulence and competitive fitness in a chinchilla model of Haemophilus influenzae otitis media","volume":"5","author":"Morton","year":"2012","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.vaccine.2020.02.054_b0145","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.mimet.2012.10.005","article-title":"Signature-tagging of a bacterial isolate demonstrates phenotypic variability of the progeny in vivo in the absence of defined mutations","volume":"91","author":"Whitby","year":"2012","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.vaccine.2020.02.054_b0150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.micpath.2003.08.007","article-title":"Reduced severity of middle ear infection caused by nontypeable Haemophilus influenzae lacking the hemoglobin\/hemoglobin-haptoglobin binding proteins (Hgp) in a chinchilla model of otitis media","volume":"36","author":"Morton","year":"2004","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2020.02.054_b0155","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1128\/iai.52.1.183-191.1986","article-title":"Genetic relationships of serologically nontypable and serotype b strains of Haemophilus influenzae","volume":"52","author":"Musser","year":"1986","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.02.054_b0160","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0264-410X(98)00150-9","article-title":"Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments","volume":"17","author":"Dale","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.054_b0165","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1128\/IAI.70.4.2171-2177.2002","article-title":"Immunogenicity of a 26-valent group A streptococcal vaccine","volume":"70","author":"Hu","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.02.054_b0170","first-page":"24","article-title":"A Cation-Binding Surface Protein as a Vaccine Antigen To Prevent Moraxella catarrhalis Otitis Media and Infections in Chronic Obstructive Pulmonary Disease","author":"Murphy","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2020.02.054_b0175","doi-asserted-by":"crossref","first-page":"13973","DOI":"10.1002\/anie.201700964","article-title":"A semi-synthetic glycoconjugate vaccine candidate for Carbapenem-resistant Klebsiella pneumoniae","volume":"56","author":"Seeberger","year":"2017","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.vaccine.2020.02.054_b0180","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1099\/jmm.0.000744","article-title":"Identification and characterization of a novel single-chain variable fragment (scFv) antibody against Neisseria meningitidis factor H-binding protein (fHbp)","volume":"67","author":"Yarian","year":"2018","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2020.02.054_b0185","doi-asserted-by":"crossref","first-page":"648","DOI":"10.2144\/97234bm22","article-title":"Simplified agar plate method for quantifying viable bacteria","volume":"23","author":"Jett","year":"1997","journal-title":"Biotechniques"},{"key":"10.1016\/j.vaccine.2020.02.054_b0190","doi-asserted-by":"crossref","first-page":"e1969","DOI":"10.1371\/journal.pone.0001969","article-title":"Strain-specific virulence phenotypes of Streptococcus pneumoniae assessed using the Chinchilla laniger model of otitis media","volume":"3","author":"Forbes","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.02.054_b0195","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1586\/erv.09.63","article-title":"Chinchilla as a robust, reproducible and polymicrobial model of otitis media and its prevention","volume":"8","author":"Bakaletz","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2020.02.054_b0200","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1099\/mic.0.27238-0","article-title":"Identification of a haem-utilization protein (Hup) in Haemophilus influenzae","volume":"150","author":"Morton","year":"2004","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2020.02.054_b0205","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1086\/344233","article-title":"Immunization with Haemophilus influenzae Hap adhesin protects against nasopharyngeal colonization in experimental mice","volume":"186","author":"Cutter","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.02.054_b0210","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1128\/IAI.66.5.1891-1897.1998","article-title":"Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis","volume":"66","author":"Gu","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.02.054_b0215","doi-asserted-by":"crossref","first-page":"6884","DOI":"10.1128\/IAI.71.12.6884-6891.2003","article-title":"Human antibodies specific for the high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae mediate opsonophagocytic activity","volume":"71","author":"Winter","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.02.054_b0220","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1128\/IAI.68.4.2119-2128.2000","article-title":"Epitope mapping of the outer membrane protein P5-homologous fimbrin adhesin of nontypeable Haemophilus influenzae","volume":"68","author":"Novotny","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.02.054_b0225","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1172\/JCI112656","article-title":"Identification of a 16,600-dalton outer membrane protein on nontypeable Haemophilus influenzae as a target for human serum bactericidal antibody","volume":"78","author":"Murphy","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2020.02.054_b0230","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1128\/IAI.69.4.2353-2363.2001","article-title":"Involvement of HxuC outer membrane protein in utilization of hemoglobin by Haemophilus influenzae","volume":"69","author":"Cope","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.02.054_b0235","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1099\/mic.0.2006\/000190-0","article-title":"The haem-haemopexin utilization gene cluster (hxuCBA) as a virulence factor of Haemophilus influenzae","volume":"153","author":"Morton","year":"2007","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2020.02.054_b0240","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1126\/science.1078973","article-title":"Role of a highly conserved bacterial protein in outer membrane protein assembly","volume":"299","author":"Voulhoux","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2020.02.054_b0245","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1021\/bi100493e","article-title":"Proteins required for lipopolysaccharide assembly in Escherichia coli form a transenvelope complex","volume":"49","author":"Chng","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2020.02.054_b0250","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1128\/IAI.68.5.2525-2534.2000","article-title":"Identification of a Haemophilus influenzae 5'-nucleotidase protein: cloning of the nucA gene and immunogenicity and characterization of the NucA protein","volume":"68","author":"Zagursky","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.02.054_b0255","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.micinf.2007.03.013","article-title":"Lipoprotein e (P4) of Haemophilus influenzae: role in heme utilization and pathogenesis","volume":"9","author":"Morton","year":"2007","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2020.02.054_b0260","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/infdis\/172.1.132","article-title":"Epidemiology of nasopharyngeal colonization with nontypeable Haemophilus influenzae in the first 2 years of life","volume":"172","author":"Faden","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.02.054_b0265","first-page":"128","article-title":"Epidemiology of nasopharyngeal colonization with nontypeable Haemophilus influenzae in the first two years of life","volume":"523","author":"Faden","year":"1996","journal-title":"Acta Otolaryngol Suppl"},{"key":"10.1016\/j.vaccine.2020.02.054_b0270","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/00365549509032722","article-title":"Characterization of Haemophilus influenzae isolates from the respiratory tract of patients with primary antibody deficiencies: evidence for persistent colonizations","volume":"27","author":"Samuelson","year":"1995","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.02.054_b0275","first-page":"1576","article-title":"Adjuvanted herpes zoster subunit vaccine in older adults","volume":"373","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.02.054_b0280","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.4049\/jimmunol.0901071","article-title":"Genetically detoxified pertussis toxin induces Th1\/Th17 immune response through MAPKs and IL-10-dependent mechanisms","volume":"183","author":"Nasso","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.02.054_b0285","doi-asserted-by":"crossref","first-page":"e8734","DOI":"10.1371\/journal.pone.0008734","article-title":"Bordetella pertussis commits human dendritic cells to promote a Th1\/Th17 response through the activity of adenylate cyclase toxin and MAPK-pathways","volume":"5","author":"Fedele","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.02.054_b0290","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.4049\/jimmunol.1003765","article-title":"Attenuated Bordetella pertussis vaccine candidate BPZE1 promotes human dendritic cell CCL21-induced migration and drives a Th1\/Th17 response","volume":"186","author":"Fedele","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.02.054_b0295","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.coi.2019.03.006","article-title":"Pertussis vaccines and protective immunity","volume":"59","author":"Kapil","year":"2019","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2020.02.054_b0300","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1038\/nm1209","article-title":"Vaccines: past, present and future","volume":"11","author":"Plotkin","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2020.02.054_b0305","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002234","article-title":"Rational design of a meningococcal antigen inducing broad protective immunity","volume":"3","author":"Scarselli","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2020.02.054_b0310","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/cid\/cix234","article-title":"Emergence of Invasive Haemophilus influenzae Type A Disease in Italy","volume":"64","author":"Giufre","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.02.054_b0315","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1016\/j.vaccine.2018.09.060","article-title":"Increasing trend in invasive non-typeable Haemophilus influenzae disease and molecular characterization of the isolates, Italy, 2012\u20132016","volume":"36","author":"Giufre","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.054_b0320","article-title":"Resurgence of pneumococcal meningitis in Europe and Northern America","author":"Koelman","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2020.02.054_b0325","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3389\/fimmu.2019.01344","article-title":"Pertussis prevention: reasons for resurgence, and differences in the current acellular pertussis vaccines","volume":"10","author":"Esposito","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2020.02.054_b0330","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vaccine.2016.11.065","article-title":"Structure-based design of broadly protective group a streptococcal M protein-based vaccines","volume":"35","author":"Dale","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.054_b0335","doi-asserted-by":"crossref","first-page":"ftv073","DOI":"10.1093\/femspd\/ftv073","article-title":"Contribution of pertussis toxin to the pathogenesis of pertussis disease","volume":"73","author":"Carbonetti","year":"2015","journal-title":"Pathog Dis"},{"key":"10.1016\/j.vaccine.2020.02.054_b0340","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/bs.apcsb.2018.01.006","article-title":"In silico tools and databases for designing peptide-based vaccine and drugs","volume":"112","author":"Usmani","year":"2018","journal-title":"Adv Protein Chem Struct Biol"},{"key":"10.1016\/j.vaccine.2020.02.054_b0345","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1039\/C5SC03892H","article-title":"Peptide-based synthetic vaccines","volume":"7","author":"Skwarczynski","year":"2016","journal-title":"Chem Sci"},{"key":"10.1016\/j.vaccine.2020.02.054_b0350","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.sbi.2014.05.010","article-title":"Computational enzyme design: transitioning from catalytic proteins to enzymes","volume":"27","author":"Mak","year":"2014","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.vaccine.2020.02.054_b0355","doi-asserted-by":"crossref","first-page":"10005","DOI":"10.1038\/ncomms10005","article-title":"Integrative genomic mining for enzyme function to enable engineering of a non-natural biosynthetic pathway","volume":"6","author":"Mak","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2020.02.054_b0360","doi-asserted-by":"crossref","first-page":"e1002477","DOI":"10.1371\/journal.pcbi.1002477","article-title":"Computational design of a PDZ domain peptide inhibitor that rescues CFTR activity","volume":"8","author":"Roberts","year":"2012","journal-title":"PLoS Comput Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20302772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20302772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:42:29Z","timestamp":1759401749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20302772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":72,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0264410X20302772"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.054","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A bacterial vaccine polypeptide protective against nontypable Haemophilus influenzae","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}